hyperphosphorylated tau drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (3)
Papers in which this entity is mentioned.
- Towards understandings of serine/arginine-rich splicing factors. (2023)
- Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing. (2021)
- Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. (2012)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| tau | drug | 16 | 19 |
| hyperphosphorylated tau | drug | 5 | 5 |
| hyperphosphorylated tau | phenotype | 5 | 8 |
| hyperphosphorylated tau epitopes | drug | — | — |